• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Grand Rounds

Can Ultrasonography in Addition to Mammography Improve Breast Cancer Screening Effectiveness?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Whole-breast ultrasonography in addition to mammography has been suggested to improve outcomes in women with dense breasts as well as those at high risk for other reasons (e.g., personal history of breast cancer)
    • Data remains limited as to benefits
  • Lee et al. (JAMA Intern Med, 2019) sought to determine, in community practice, the performance of
    • Screening mammography alone
    • Screening mammography plus screening ultrasonography

METHODS:

  • Observational cohort study
  • Participants and data collection
    • Prospectively collected data
    • Same day ultrasound available
    • Data linked to Breast Cancer Surveillance Consortium registries
    • Exclusion criteria: Personal history of breast cancer | Self-reported breast symptoms
  • Exposures
    • Screening mammography alone
    • Screening mammography with screening ultrasonography
  • Screening mammography plus screening ultrasonography matched 1:5 to mammograms without screening ultrasonography for the following
    • Age | Year of examination, Race/ethnicity | Menopausal status | First-degree family history of breast cancer | Time since last mammogram | Breast density | Prior benign biopsy result
  • Primary outcomes
    • Cancer detection rate and rates of interval cancer
    • False-positive biopsy recommendation
    • Short-interval follow-up
    • PPV of biopsy
  • Propensity score used to address confounding as well as direct adjustments

RESULTS:

  • Screening mammograms with screening ultrasonography: 3386 women | 6081 exams
  • Screening mammograms without ultrasonography: 15,176 women | 30,062 from a sample of 113,293 mammograms

Despite matching, screening mammography with ultrasonography was performed more often in women with the following characteristics

  • Dense breasts
    • With ultrasonography: 74.3%
    • Without ultrasonography: 35.9%
  • <50 years old
    • With ultrasonography: 49.7%
    • Without ultrasonography: 31.7%
  • Family history of breast cancer
    • With ultrasonography: 42.9%
    • Without ultrasonography: 15.0%
  • At higher risk for breast cancer
    • High or very high (≥2.50%) Breast Cancer Surveillance Consortium 5-year risk scores: 21.4%
    • Women with low or average (<1.67%) risk: 53.6%
  • Cancer detection rate was similar in both groups
    • With ultrasonography: 5.4 per 1000 screens
    • Without ultrasonography: 5.5 per 1000 screens
    • Adjusted relative risk (RR), 1.14 (95% CI, 0.76-1.68)
  • Interval cancer rates were similar in both groups
    • With ultrasonography: 1.5 per 1000 screens
    • Without ultrasonography: 1.9 per 1000 screens
    • RR 0.67 (95% CI, 0.33-1.37)
  • False-positive biopsy rates were significantly higher in the with ultrasonography group
    • With ultrasonography: 52.0 per 1000 screens
    • Without ultrasonography: 22.2 per 1000 screens
    • RR 2.23 (95% CI, 1.93-2.58)
  • Short-interval follow-up was significantly higher in the with ultrasonography group
    • With ultrasonography: 3.9%
    • Without ultrasonography: 1.1%
    • RR 3.10 (95% CI, 2.60-3.70)
  • PPV of biopsy recommendation was significantly lower in the with ultrasonography group
    • With ultrasonography: 9.5%
    • Without ultrasonography: 21.4%
    • RR 0.50 (95% CI, 0.35-0.71)

CONCLUSION:

  • Authors conclude that benefits of supplemental ultrasound across all risk categories did not appear to outweigh the harms of additional biopsies  

Learn More – Primary Sources:

Performance of Screening Ultrasonography as an Adjunct to Screening Mammography in Women Across the Spectrum of Breast Cancer Risk

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone, with ObGFirst

Learn More  »

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

ACOG Reaffirms Breast Density Guidance – FDA Proposes New Notification Rule
Mammography Guidelines for Average-Risk Women
BI-RADS: Standardizing Breast Imaging and Reporting 
Breast Cancer Screening using MRI vs Mammography – How Do They Compare?
How Effective Is Mammography in Reducing the Number of Advanced Breast Cancer Diagnoses?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site